Garner RC - Search Results

1

Macromolecular adduct formation and metabolism of heterocyclic amines in humans and rodents at low doses.

Turteltaub KW, Dingley KH, Curtis KD, Malfatti MA, Turesky RJ, Garner RC, Felton JS, Lang NP. Turteltaub KW, et al. Among authors: garner rc. Cancer Lett. 1999 Sep 1;143(2):149-55. doi: 10.1016/s0304-3835(99)00116-0. Cancer Lett. 1999. PMID: 10503895

2

MeIQx-DNA adduct formation in rodent and human tissues at low doses.

Turteltaub KW, Mauthe RJ, Dingley KH, Vogel JS, Frantz CE, Garner RC, Shen N. Turteltaub KW, et al. Among authors: garner rc. Mutat Res. 1997 May 12;376(1-2):243-52. doi: 10.1016/s0027-5107(97)00049-3. Mutat Res. 1997. PMID: 9202761

3

Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats.

Dingley KH, Freeman SP, Nelson DO, Garner RC, Turteltaub KW. Dingley KH, et al. Among authors: garner rc. Drug Metab Dispos. 1998 Aug;26(8):825-8. Drug Metab Dispos. 1998. PMID: 9698300

4

Comparison of DNA-adduct and tissue-available dose levels of MeIQx in human and rodent colon following administration of a very low dose.

Mauthe RJ, Dingley KH, Leveson SH, Freeman SP, Turesky RJ, Garner RC, Turteltaub KW. Mauthe RJ, et al. Among authors: garner rc. Int J Cancer. 1999 Feb 9;80(4):539-45. doi: 10.1002/(sici)1097-0215(19990209)80:4<539::aid-ijc10>3.0.co;2-c. Int J Cancer. 1999. PMID: 9935154

5

Comparative biotransformation studies of MeIQx and PhIP in animal models and humans.

Garner RC, Lightfoot TJ, Cupid BC, Russell D, Coxhead JM, Kutschera W, Priller A, Rom W, Steier P, Alexander DJ, Leveson SH, Dingley KH, Mauthe RJ, Turteltaub KW. Garner RC, et al. Cancer Lett. 1999 Sep 1;143(2):161-5. doi: 10.1016/s0304-3835(99)00118-4. Cancer Lett. 1999. PMID: 10503897

6

The formation of AFB(1)-macromolecular adducts in rats and humans at dietary levels of exposure.

Cupid BC, Lightfoot TJ, Russell D, Gant SJ, Turner PC, Dingley KH, Curtis KD, Leveson SH, Turteltaub KW, Garner RC. Cupid BC, et al. Among authors: garner rc. Food Chem Toxicol. 2004 Apr;42(4):559-69. doi: 10.1016/j.fct.2003.10.015. Food Chem Toxicol. 2004. PMID: 15019179

7

Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans.

Turesky RJ, Garner RC, Welti DH, Richoz J, Leveson SH, Dingley KH, Turteltaub KW, Fay LB. Turesky RJ, et al. Among authors: garner rc. Chem Res Toxicol. 1998 Mar;11(3):217-25. doi: 10.1021/tx9701891. Chem Res Toxicol. 1998. PMID: 9544620 Clinical Trial.

8

Molecular cancer epidemiology can predict risk.

Garner RC, Dingley K, Dale CM. Garner RC, et al. BMJ. 1995 Jan 14;310(6972):124-5. doi: 10.1136/bmj.310.6972.124a. BMJ. 1995. PMID: 7833705 Free PMC article. No abstract available.

9

Tamoxifen DNA damage detected in human endometrium using accelerator mass spectrometry.

Martin EA, Brown K, Gaskell M, Al-Azzawi F, Garner RC, Boocock DJ, Mattock E, Pring DW, Dingley K, Turteltaub KW, Smith LL, White IN. Martin EA, et al. Among authors: garner rc. Cancer Res. 2003 Dec 1;63(23):8461-5. Cancer Res. 2003. PMID: 14679010

10

A preliminary evaluation of accelerator mass spectrometry in the biomedical field.

Kaye B, Garner RC, Mauthe RJ, Freeman SP, Turteltaub KW. Kaye B, et al. Among authors: garner rc. J Pharm Biomed Anal. 1997 Nov;16(3):541-3. doi: 10.1016/s0731-7085(97)00104-0. J Pharm Biomed Anal. 1997. PMID: 9589415 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters